[DPLO] Diplomat Pharmacy, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Nursing Services

Market Capitalization:

Exchange: NYSE

The data is delayed by 15 minutes.

 

Price: 12.99 Change: -0.02 (-0.15%)
Ext. hours: Change: 0 (0%)

chart DPLO

Refresh chart

Strongest Trends Summary For DPLO

DPLO is in the medium-term down -80% in 1 year. In the long-term down -90% below S&P in 6 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. The company stocks, dispenses, and distributes prescriptions for various biotech and specialty pharmaceuticals. It also provides specialty infusion pharmacy, patient care coordination, clinical, compliance and persistency program, patient financial assistance, specialty pharmacy training/consulting, benefits investigation, prior authorization, risk evaluation and medication strategy, retail specialty, and hub services, as well as clinical and administrative support services to hospitals and health systems. The company offers its solutions in range of specialty therapeutic categories, including oncology, immunology, hepatitis, multiple sclerosis, HIV, and infusion therapy. Diplomat Pharmacy, Inc. has seven pharmacy locations in Michigan, Illinois, Florida, California, Connecticut, and Massachusetts. The company was founded in 1975 and is headquartered in Flint, Michigan.

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 15.36% Sales Growth - Q/Q2.09% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA1.09% ROE1.86% ROI
Current Ratio2.09 Quick Ratio1.58 Long Term Debt/Equity Debt Ratio0.66
Gross Margin6.39% Operating Margin0.48% Net Profit Margin0.25% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities152.07 M Cash From Investing Activities-3.91 M Cash From Operating Activities-4.1 M Gross Profit41.14 M
Net Profit2.86 M Operating Profit4.84 M Total Assets544.8 M Total Current Assets444.79 M
Total Current Liabilities212.69 M Total Debt4.7 M Total Liabilities224.46 M Total Revenue624.88 M
Technical Data
High 52 week28.13 Low 52 week5.21 Last close5.22 Last change-1.32%
RSI40 Average true range0.31 Beta1.09 Volume808.56 K
Simple moving average 20 days-7.21% Simple moving average 50 days-8.83% Simple moving average 200 days-65.72%
Performance Data
Performance Week-12.12% Performance Month0.19% Performance Quart-62.04% Performance Half-72.58%
Performance Year-73.97% Performance Year-to-date-65.66% Volatility daily2.37% Volatility weekly5.3%
Volatility monthly10.86% Volatility yearly37.63% Relative Volume189.12% Average Volume1.5 M
New High New Low

News

2019-06-26 18:29:41 | Here’s What Hedge Funds Think About Diplomat Pharmacy Inc DPLO

2019-06-26 13:26:43 | Is It Too Late To Consider Buying Diplomat Pharmacy, Inc. NYSE:DPLO?

2019-06-26 13:23:22 | Is There Now An Opportunity In Diplomat Pharmacy, Inc. NYSE:DPLO?

2019-06-10 07:00:43 | How Does Investing In Diplomat Pharmacy, Inc. NYSE:DPLO Impact The Volatility Of Your Portfolio?

2019-05-23 13:23:13 | Diplomat Pharmacy, Inc. -- Moody's announces completion of a periodic review of ratings of Diplomat Pharmacy, Inc.

2019-05-13 16:54:00 | Waiting on Diplomat Pharmacy to Rebuild

2019-05-10 10:31:02 | New Strong Sell Stocks for May 10th

2019-05-07 15:27:23 | Edited Transcript of DPLO earnings conference call or presentation 7-May-19 12:30pm GMT

2019-05-07 13:23:28 | Diplomat Pharmacy Inc DPLO Q1 2019 Earnings Call Transcript

2019-05-07 09:05:01 | Diplomat Pharmaceuticals DPLO Reports Q1 Loss, Tops Revenue Estimates

2019-05-07 07:59:18 | Diplomat Pharmaceuticals: 1Q Earnings Snapshot

2019-05-07 07:30:00 | Diplomat Announces 1st Quarter Financial Results

2019-05-06 16:30:00 | Diplomat Appoints Dave Loschinskey as Chief Operating Officer

2019-05-03 10:15:14 | Is Diplomat Pharmacy Inc DPLO A Good Stock To Buy?

2019-04-30 10:32:02 | Diplomat Pharmaceuticals DPLO Expected to Beat Earnings Estimates: Should You Buy?

2019-04-30 07:15:00 | NYSE: DPLO Investor Notice: Lawsuit against Diplomat Pharmacy Inc announced by Shareholders Foundation

2019-04-25 21:27:18 | APRIL 25 DEADLINE: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Diplomat Pharmacy, Inc. DPLO and Encourages DPLO Investors to Contact the Firm

2019-04-25 17:50:00 | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of DPLO, INGN and BPI

2019-04-25 16:30:00 | Diplomat Using SMRxT Technology to Enhance Patient Care

2019-04-25 16:15:00 | DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Diplomat Pharmacy, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-04-25 14:40:00 | SHAREHOLDER ALERT: DPLO INGN BPI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

2019-04-25 11:21:57 | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of DPLO, CVS, UMC and AAPL

2019-04-25 10:15:00 | Final Deadline DPLO & AVEO Bronstein, Gewirtz & Grossman, LLC

2019-04-25 08:30:00 | THURSDAY DEADLINE REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Diplomat Pharmacy, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-04-24 22:50:00 | DIPLOMAT PHARMACY 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit against Diplomat Pharmacy, Inc. - DPLO

2019-04-24 18:20:00 | CLASS ACTION UPDATE for DPLO, HCSG and BA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

2019-04-24 17:55:00 | FINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Diplomat Pharmacy, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-04-24 14:00:00 | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of DPLO, SYNH and CRBP

2019-04-24 11:12:00 | DEADLINE THURSDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Diplomat Pharmacy, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-04-24 11:00:59 | CLASS ACTION UPDATE for DPLO, WTW, EB and AAPL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

2019-04-23 18:45:00 | APRIL 25 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Diplomat Pharmacy, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-04-23 18:30:00 | CLASS ACTION UPDATE for AVEO, DPLO and S: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

2019-04-23 18:23:35 | DPLO FINAL DEADLINE REMINDER: Rosen Law Firm Reminds Diplomat Pharmacy, Inc. Investors of Important April 25th Deadline in Securities Class Action Filed by the Firm – DPLO

2019-04-23 15:45:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Diplomat Pharmacy, Inc. of Class Action Lawsuit and Upcoming Deadline - DPLO

2019-04-23 15:35:00 | FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of DPLO, CTL and ARA

2019-04-23 15:00:00 | Class Action Alert CAG, DPLO & AVEO Bronstein, Gewirtz & Grossman, LLC

2019-04-23 11:17:00 | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AVEO, DPLO and EB

2019-04-23 10:14:00 | Final Deadline CAG, DPLO & AVEO Bronstein, Gewirtz & Grossman, LLC

2019-04-22 13:15:00 | CLASS ACTION UPDATE for DPLO, CAG and CVS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

2019-04-22 11:49:56 | SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS DPLO, BA, WTW, BPI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

2019-04-22 10:25:00 | FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of DPLO, FSNN and AAPL

2019-04-19 22:50:00 | SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS DPLO, BA, WTW, CTL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

2019-04-18 15:50:00 | SHAREHOLDER ALERT: DPLO MBT AAPL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

2019-04-18 14:17:02 | DPLO DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Diplomat Pharmacy, Inc. – DPLO

2019-04-18 13:45:00 | 7-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Diplomat Pharmacy, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-04-18 13:10:00 | SHAREHOLDER ALERT: DPLO VNDA BA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

2019-04-18 13:08:50 | SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS DPLO, BA, CVS, BPI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

2019-04-18 12:14:45 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Diplomat Pharmacy, Inc. of Class Action Lawsuit and Upcoming Deadline – DPLO

2019-04-18 10:11:46 | CLASS ACTION UPDATE for CORT, AVEO, DPLO and MBT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

2019-04-18 06:00:00 | Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Health Insurance, Kraft Heinz, Diplomat, and Stamps.com and Encourages Investors to Contact the Firm